A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers, Rheumatoid Arthritis

In brief

This double-blind, randomized, placebo-controlled study will assess the safety and pharmacokinetics of ZB002 in healthy participants and in participants with rheumatoid arthritis (RA). The study consists of 2 parts. Part A: Single Ascending Dose (SAD), which will include only healthy volunteers. Part B: Multiple Ascending Dose (MAD), will commence after completion of the SAD study and will include RA participants.

Key facts

Study ID

NCT05638854

Run by

Zenas BioPharma (USA), LLC

People needed

72

Starts

2022-12-08

Expected to finish

2025-07-01

Last updated by the study team

2025-04-08

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• NZCR New Zealand Clinical Research — Christchurch, New Zealand (enrolling)
• Veritus Research — Melbourne, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.